Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.91
+0.02 (0.25%)
At close: Sep 16, 2026, 4:00 PM EDT
7.91
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Cartesian Therapeutics Employees
Cartesian Therapeutics had 75 employees as of December 31, 2025. The number of employees increased by 9 or 13.64% compared to the previous year.
Employees
75
Change (1Y)
9
Growth (1Y)
13.64%
Revenue / Employee
$19,693
Profits / Employee
-$2,025,213
Market Cap
239.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 9 | 13.64% | 75 | 0 |
| Dec 31, 2024 | 66 | 28 | 73.68% | 66 | 0 |
| Dec 31, 2023 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Entrada Therapeutics | 152 |
| Foghorn Therapeutics | 106 |
| Alector | 103 |
| Compugen | 75 |
| Protara Therapeutics | 46 |
| Anavex Life Sciences | 34 |
| Whitehawk Therapeutics | 32 |
RNAC News
- 8 days ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 13 days ago - Cartesian Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Cartesian Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Cartesian Therapeutics Earnings release: Q2 2026 - Filings
- 3 months ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 3 months ago - Cartesian Therapeutics Transcript: AGM 2026 - Transcripts
- 3 months ago - Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases - GlobeNewsWire